Division of Endocrinology & Metabolism
Division Research
Collaborative research across disciplines is the key distinguishing characteristic of the Division. All members of the division are directly or indirectly involved in research. Several members are pursuing an extensive program of research related to diabetes, dysglycemia, cardiovascular disease, renal disease and osteoporosis. These are done in close collaboration with members of other divisions, the Department of CE&B, the Population Health Research Institute, the Centre for Evaluative Medicines, and other universities around the world. They include:
- Publication of 25+ peer-reviewed articles in the 2003-2004 academic year
- International leadership of, and participation in several international clinical trials testing the efficacy of various approaches to prevent cardiovascular events, erectile dysfunction, cognitive dysfunction, and retinal disease in dysglycemic individuals with diabetes or “pre-diabetes”
- International leadership of, and participation in large international clinical trials testing various ways of preventing and treating obesity, diabetes and atherosclerosis
- Assessment of simple public health tools for diabetes self-management in the community (Diabetes Hamilton and IN-CHARGE)
- The role of dysglycemia as a risk factor for cardiovascular outcomes and cognitive dysfunction
- Innovative approaches to treating osteoporosis and assessing bone mass


